viernes, 7 de noviembre de 2025
Editorial e747 Psoriatic arthritis: strategy shaping treatment The Lancet Rheumatology + + + +...
Synovial immunopathology in psoriatic arthritis: cellular and molecular insights
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00231-0/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-86Y3EWdJgBkvpCXRg0Jqo0pNdYifcmQH_GoHbZi-daL4UbU86sp9GM33P-X6H1NZYEgq5uZCghZJ-fxCU2PnRuTvhqgQ&_hsmi=388534661&utm_content=387635667&utm_source=hs_email
Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00102-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanrhe&utm_campaign=update-lanrhe&utm_medium=email&_hsenc=p2ANqtz-8FDkizLNU2ciIX9eRHoLvYFJ_6FGJjjrpPsDwzBIZ0pr5h9dDmiwVHpMoknlW5Ed0nIUI02AUBLFetOXNqt4rlv9-nWw&_hsmi=388534661&utm_content=387635667&utm_source=hs_email
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00156-0/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-9cDpP9vaioQmtuwO9uqtLCjQsQxDQI5w6pQpX6Xno9U-vlvBdFYbW_PheUpfEjxcKMEVFUmDNglqmIGalGaTZ8xJi64w&_hsmi=388534661&utm_content=387635667&utm_source=hs_email
Editorial
e747
Psoriatic arthritis: strategy shaping treatment
The Lancet Rheumatology
https://www.thelancet.com/journals/lanrhe/issue/vol7no11/PIIS2665-9913(25)X0011-4
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario